Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

However, the case group had significantly lower HDL and higher HbA1c, TG, uric acid, BUN, Cr and eGFR compared with control group (p < 0.05).The biochemical metabolic and bone turnover markers in diabetic patients who developed microvascular complications compared with those without microvascular complicationsBaseline characteristicsWith DR and/or DN N = 104 (mean ± SE)Without DR /DN N = 100 (mean ± SE) p-valueFBS (mg/dL)134.81 ± 1.51134.92 ± 1.030.98Insulin (μU/L)11.51 ± 0.159.08 ± 0.210.068HbA1c (%)8.08 ± 0.197.37 ± 0.140.003TG (mg/dL)132.55 ± 0.16115.16 ± 0.150.036HDL (mg/dL)44.10 ± 1.0949.58 ± 1.050.0001LDL (mg/dL)80.19 ± 0.1379.11 ± 0.130.78TC (mg/dL)148.91 ± 0.12148.99 ± 0.120.99Cr (μmol/L)113.42 ± 0.1487.51 ± 0.130.0001BUN (mg/dL)20.59 ± 0.1415.18 ± 0.130.0001Uric-acid (mg/dL)5.63 ± 0.155.63 ± 0.130.002eGFR89.02 ± 3.0776.18 ± 2.700.0001AST (U/L)17.79 ± 0.2320.65 ± 0.240.56ALT (U/L)21.73 ± 0.2521.73 ± 0.230.13PTH (pg/mL)46.64 ± 3.9134.22 ± 1.440.00125(OH)D (nmol/L)27.24 ± 2.1733.25 ± 1.990.04OC (ng/mL)17.88 ± 0.1913.32 ± 0.160.0001CTX (ng/mL)0.28 ± 0.020.24 ± 0.010.06P1NP (pg/mL)86.19 ± 0.3671.52 ± 0.400.33 DN Diabetic nephropathy, DR Diabetic retinopathy, FBS fasting blood sugar, TG triglyceride, HbA1c hemoglobin A1c, HDL high-density lipoprotein, LDL low-density lipoprotein, TC total cholesterol, Cr creatinine, BUN blood urea nitrogen, AST aspartate aminotransferase, ALT alanine aminotransferase, PTH Intact parathyroid hormone, 25(OH)D 25 (OH) vitamin D, OC osteocalcin, CTX carboxy-terminal collagen crosslinks, P1NP procollagen I aminoterminal propeptide, eGFR estimated glomerular filtration

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A total of 204 type 2 diabetes patients (104 patients with diabetic micro-vascular complications (retinopathy and/or nephropathy) as a case group and 100 patients without retinopathy and/or nephropathy) as a control group were recruited in this case: control study.

Source: Abstract.

All patients were type 2 diabetes without any history of cancer or chronic disorders.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The association between bone turnover markers and microvascular complications of type 2 diabetes

Case-control study · Journal of Diabetes and Metabolic Disorders · 2016

Original publication title

The association between bone turnover markers and microvascular complications of type 2 diabetes

Zhila Maghbooli; Parisa Shabani; Sattar Gorgani-Firuzjaee; Arash Hossein-nezhad

© The Author(s). 2016

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our data suggest the possible role of PTH and BUN levels in modulating bone turnover markers in diabetic patients.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Global epidemic of diabetes is a serious health care concern because of its complications and consequently reduced life expectancy and increased morbidity. However, the bone turnover and thus bone health may be affected or even compromised by diabetes and its complications. The aim of this study was to assess whether bone turnover markers are associated with diabetes micro-vascular complications.

Source: Background

Abstract: What methods does the paper describe?

A total of 204 type 2 diabetes patients (104 patients with diabetic micro-vascular complications (retinopathy and/or nephropathy) as a case group and 100 patients without retinopathy and/or nephropathy) as a control group were recruited in this case: control study. The biochemical and metabolic parameters and bone turnover markers were assessed in all patients.

Source: Methods

Abstract: Results

Our findings showed serum levels of osteocalcin (OC) (p = 0.0001) and, carboxy-terminal collagen crosslinks (CTX) (p = 0.006) were higher in diabetic patients with both diabetic retinopathy and nephropathy compared with control group. However, there was no significant difference in serum levels of procollagen I aminoterminal propeptide (P1NP) between diabetic patients with diabetic retinopathy (DR) and/or diabetic nephropathy (DN) compared with control.

In diabetes patients with complications, there were significant negative correlation between OC and CTX with estimated-glomerular filtration rate (e-GFR) and also positive correlation between each bone marker (OC and CTX) and PTH levels (p = 0.0001) and BUN (p = 0.0001).

In a general linear model, after adjusting for age, sex and BMI, and microvascular complications, there was not any significant association between three bone turnover markers and metabolic markers including fasting glucose, insulin, and lipid profile. Among kidney markers, there were significant positive associations between serum levels of CTX and OC with BUN (p < 0.05) as well as PTH (p < 0.0001).

Source: Results Source: Results Source: Results

Abstract: Conclusions

Our data suggest the possible role of PTH and BUN levels in modulating bone turnover markers in diabetic patients.

Source: Conclusions
Authors’ abstract

Background

Global epidemic of diabetes is a serious health care concern because of its complications and consequently reduced life expectancy and increased morbidity. However, the bone turnover and thus bone health may be affected or even compromised by diabetes and its complications. The aim of this study was to assess whether bone turnover markers are associated with diabetes micro-vascular complications.

Methods

A total of 204 type 2 diabetes patients (104 patients with diabetic micro-vascular complications (retinopathy and/or nephropathy) as a case group and 100 patients without retinopathy and/or nephropathy) as a control group were recruited in this case: control study. The biochemical and metabolic parameters and bone turnover markers were assessed in all patients.

Results

Our findings showed serum levels of osteocalcin (OC) (p = 0.0001) and, carboxy-terminal collagen crosslinks (CTX) (p = 0.006) were higher in diabetic patients with both diabetic retinopathy and nephropathy compared with control group. However, there was no significant difference in serum levels of procollagen I aminoterminal propeptide (P1NP) between diabetic patients with diabetic retinopathy (DR) and/or diabetic nephropathy (DN) compared with control.

In diabetes patients with complications, there were significant negative correlation between OC and CTX with estimated-glomerular filtration rate (e-GFR) and also positive correlation between each bone marker (OC and CTX) and PTH levels (p = 0.0001) and BUN (p = 0.0001).

In a general linear model, after adjusting for age, sex and BMI, and microvascular complications, there was not any significant association between three bone turnover markers and metabolic markers including fasting glucose, insulin, and lipid profile. Among kidney markers, there were significant positive associations between serum levels of CTX and OC with BUN (p < 0.05) as well as PTH (p < 0.0001).

Conclusions

Our data suggest the possible role of PTH and BUN levels in modulating bone turnover markers in diabetic patients.

Publication and source details

Original title: The association between bone turnover markers and microvascular complications of type 2 diabetes

Zhila Maghbooli; Parisa Shabani; Sattar Gorgani-Firuzjaee; Arash Hossein-nezhad

Journal of Diabetes and Metabolic Disorders · 2016

© The Author(s). 2016https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences 00187Hossein-nezhad Arash

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:55:09.696390+00:00

DOI: 10.1186/s40200-016-0274-2 · PMC5100233